To investigate the association of pericardial, mediastinal, and intrathoracic fat volumes with the presence and severity of coronary artery disease (CAD), metabolic syndrome (MS), and cardiac risk factors (CRFs).
Introduction
Recent studies have shown that the distribution of fat is a stronger predictor of coronary artery disease (CAD) than the overall body fat quantity. 1 -3 Abdominal visceral fat exerts a systemic effect on atherosclerosis by increasing the expression of inflammatory markers. 4, 5 Strong correlation has been reported between abdominal visceral fat, CAD, and metabolic syndrome (MS). 4, 5 Intrathoracic fat has also been shown to have a pro-inflammatory activity similar to that found in abdominal visceral fat. 3 -8 The contribution of intrathoracic fat to the systemic effect on atherosclerosis might be limited, due to the smaller amount of fat when compared with abdominal fat. However, due to its close proximity to coronary arteries, it is hypothesized to have a local effect on the development of CAD. 1 -8 Intrathoracic fat consists of pericardial fat and mediastinal fat. Studies have reported an association between pericardial fat, CAD, and MS; and total intrathoracic fat with CAD. 5 -10 However, the relationship between mediastinal fat, CAD, and MS is not clear. Furthermore, whether pericardial fat has a stronger association with CAD (due to its close proximity to the coronary arteries) than mediastinal fat is not yet known. We aim to investigate the association of pericardial, mediastinal, and intrathoracic fat volumes quantified by cardiac magnetic resonance (CMR) with the presence and severity of CAD, MS, cardiac risk factors (CRFs), and the development of death or myocardial infarction upon follow-up.
Methods Population
Two hundred and twenty consecutive patients between 18 and 90 years old who underwent CMR and coronary angiography within 12 months at our institution from 2006 to 2009 were initially evaluated; four patients were excluded based on inadequate CMR image quality. The final study population consisted of 216 patients. At the time of CMR, IRB-approved consent was obtained from all participating patients. Blood was drawn for laboratory testing including a fasting lipid panel.
Assessment of CAD
Conventional X-ray coronary angiography was performed using standard techniques in all 216 patients. Interpretation of angiography was performed by an experienced physician who was unaware of the patients' clinical information or CMR results in 189 cases; the remaining 27 cases were interpreted based on the clinicians report due to an inability to obtain angiography images from our archive system. Significant CAD was defined as any stenosis of ≥75% on angiogram by visual assessment and severity of CAD was determined based on the Duke CAD Jeopardy Score. This scoring system is a quantitative system in which the coronary circulation is considered as six arterial segments: the left anterior descending artery, the diagonal branches, the first major septal perforator, the left circumflex artery, the circumflex marginal branch, and the posterior descending artery (Figure 1 ). In patients with a left dominant system, the right coronary artery is assigned no points. Each segment with luminal stenosis of ≥75% or a branch distal to a stenosis of ≥75% received a score of 2 points; thus, the maximal score is 12 points.
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A site of prior stent was considered as significant stenosis and was scored appropriately. In patients with prior coronary artery bypass grafting, scoring was based on stenosis found in native vessels only.
Cardiovascular magnetic resonance
Images were acquired using a 1.5-T clinical scanner (Siemens Sonata) using a six-channel phased-array receiver coil. Steady-state free precession cine images were acquired in multiple short-axis and three long-axis views during repeated breath holds (mean duration of 6-8 s). Typical imaging parameters were as follows: repetition time 3.0 ms, echo time 1.5 ms, flip angle: 608, temporal resolution 35 ms, and voxel size 1.7 × 1.4 × 6 mm.
Pericardial fat was defined as the fat observed over the free wall of the right ventricle, apex, and the anterior region of the left ventricle (LV) within the parietal pericardium (Figures 2 and 3) . Mediastinal fat was defined as the fat present within the thoracic cavity external to the parietal pericardium (Figure 2 and 3) . Intrathoracic fat was defined as the combination of pericardial and mediastinal fat. Fat ratio was defined as the ratio between pericardial fat and mediastinal fat. Fat volume was measured from 6 to 8 consecutive cine views, obtained in the short-axis plane and covering the heart from base to apex. Fat surface area was measured by drawing the region of interest curves on each slice. Each slice measured 6 mm in thickness and a gap of 4 mm between slices was used, thus each slice represented a thickness of 1 cm (Figure 3) . Fat surface area obtained on each slice was multiplied by 1 cm thickness and then summed to obtain the fat volume. Since the mediastinal fat was not fully represented by the short-axis views, mediastinal fat surface area was also measured from a single four-chamber view and multiplied by 1 cm, and this was added to the total mediastinal fat volume obtained from the short-axis views ( Figure 2 ).
Inter-reader reliability
Two different readers performed fat volume measurements. For the assessment of inter-reader reliability of fat measurements, the intraclass Association between pericardial fat volume with the presence and severity of CAD correlation coefficient was calculated on a sample consisting of 20 patients that were measured independently by each of the two readers and blinded to the results of the other reader.
Definition of terms
Data on CRFs were obtained from the medical history taken at the time of CMR. We included both modifiable and non-modifiable risk factors such as hypertension (HTN), diabetes mellitus (DM), hyperlipidaemia, renal disease, smoking, and family history of premature CAD defined as symptomatic CAD in a male first-degree relative before age 55, or a female first-degree relative before age 65.
MS was defined as the presence of at least three of the following five parameters: obesity (BMI ≥30 kg/m 2 ), serum triglycerides ≥150 mg/dL, HDL cholesterol ,40 in males and ,50 in females, HTN, and DM. HDL cholesterol and triglycerides levels were obtained from results of fasting samples taken on the day of CMR. HTN and DM were considered present in patients with a past medical history of these conditions, or receiving anti-hypertensive or anti-diabetic medication(s). Race was based on patients self-reporting. Myocardial infarction was defined as per universal definition of myocardial infarction (MI), taking into consideration symptoms, ECG, and cardiac enzymes. 12 
Follow-up
All patients included in our study (Cohort study with cross-sectional and longitudinal analysis) were followed by phone using a standardized questionnaire. Medical records were reviewed to confirm myocardial infarction. Social security death index and chart review were utilized in patients who could not be contacted by phone.
Statistical analysis
Data in text and tables are expressed as mean + standard deviation (SD) for continuous variables or n (%) for categorical variables. The significant differences between continuous variables for patients with CAD and control group were determined by the use of the T-test and for categorical variables, the Pearson chi-square test was used.
The association between the presence of CAD with pericardial fat, mediastinal fat, intrathoracic fat, and fat ratio was determined with a T-test and also with logistic regression analysis that adjusted for the relevant covariates. All the other analyses with categorical independent variables used the T-test and the Pearson correlation analysis was used when comparing two continuous variables. For the correlation of severity of CAD and fat volume, a stepwise linear regression was used, b-coefficient represents the value by which fat volume increased for every increase in the CAD score. A linear regression was performed for the correlation of fat volume and CRFs with continuous variables; b-coefficient represents the change in fat volume for an increase of 1 unit in a risk factor. In addition, measurements of fat surface area were correlated with that of total fat volume. We have also assessed the effect of BMI and LV dysfunction on the relationship between pericardial, mediastinal, and intrathoracic fat volumes and CAD using chi-square analysis. We further performed a regression analysis controlling for left ventricular function and presence of CAD. All P-values are two-sided.
Results
Baseline characteristics of patients with and without CAD are presented in Table 1 . There were 120 (56%) patients with CAD by angiography. Patients with CAD were significantly older, predominantly male (66%), had a significantly greater prevalence of diabetes, HTN, hyperlipidaemia, history of heart failure, and a lower ejection fraction (EF). There was no significant difference between patients with and without CAD regarding BMI, presence of MS, family history of CAD, or smoking history.
Reproducibility
The intraclass correlation coefficient was calculated to assess the inter-reader reliability for fat measurements; results were excellent for both mediastinal fat (r ¼ 0.94, P , 0.01) and pericardial fat (r ¼ 0.87, P , 0.01) measurements. 
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, and fat ratio (b ¼ 0.005, P ¼ 0.01). These correlations persisted with P-values of ,0.001 for all four fat measurements after performing a stepwise linear regression analysis accounting for parameters from Table 1 (see Supplementary data online, Table S1 ). 
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Subgroups of population and fat
We evaluated differences in pericardial fat, mediastinal fat, intrathoracic fat, and fat ratio in four subgroups of patients: Group A ¼ CAD(2) and MS(2), Group B ¼ CAD(+) and MS(+), Group C ¼ CAD(+) and MS(2), Group D ¼ CAD(2) and MS(+) ( Table 2) . Groups B, C, and D were compared with Group A that was considered to be a control group ( Table 2) . Pericardial fat, mediasinal fat, and intrathoracic fat were significantly greater in Group B when compared with Group A (P ¼ 0.02, P , 0.01, and P , 0.01, respectively); no statistically significant difference was found in fat ratio between those two groups (P ¼ 0.29). Mediastinal fat and intrathoracic fat were significantly greater in Group D when compared with Group A (P , 0.01 and P , 0.01, respectively); this was not true for pericardial fat and fat ratio (P ¼ 0.10 and P ¼ 0.71, respectively).
Cardiac risk factors and fat
The results for the association between pericardial, mediastinal, intrathoracic fat volume, and fat ratio with the presence of CRFs are presented in Table S1 ). While an increase in age was associated with a decrease in pericardial, mediastinal, and intrathoracic fat, significance was found only for the change in mediastinal fat (b ¼ 20.002, P ¼ 0.99; b ¼ 20.39, P ¼ 0.02; and b ¼ 20.39, P ¼ 0.16, respectively); there was no significant difference in fat ratio with advance in age. The increase in total cholesterol, LDL, and HDL cholesterol was associated with a decrease in fat volumes, but none of these findings reached statistical significance. Chi-square analysis showed that there is no interaction between CAD and BMI (x 2 ¼ 0.43).
However, an interaction was found between CAD and LV dysfunction (defined as EF ,55) (x 2 , 0.0001). On regression analysis, we also found a statistically significant reduction in pericardial, mediastinal, and intrathoracic fat volumes and a non-significant reduction in fat ratio (27, 211, 218 cm 3 , and 20.02, respectively), in patients with an EF ≥55 when controlling for the presence of CAD.
Race and fat
The results of the comparison of fat volume within the three race groups such as whites, blacks, and other races are presented in Table 4 . When compared with other races, blacks had the least amount of pericardial, mediastinal, and intrathoracic fat volumes. Patients belonging to other races (non-black and non-whites) had more pericardial fat and fat ratio. Whites had more mediastinal fat and a higher intrathoracic fat.
Follow-up
All patients were followed for a mean 12.5 + 9.9 months. Twentyfive patients had a MI, 34 died, and 56 had a combined outcome defined as death or MI. There was no significant difference in pericardial fat, mediastinal fat, intrathoracic fat, or fat ratio between patients with or without MI during the follow-up [33. 
Correlation of fat surface area and fat volume
The correlation between measurements of pericardial, mediastinal, and intrathoracic fat volumes with those of fat surface area measured from a single four-chamber cine view revealed a weak but statistically significant correlation between two (b ¼ 0.7, P ¼ 0.02; b ¼ 0.9, P , 0.01; b ¼ 1, P , 0.01, respectively).
Discussion
The main finding of our study was the presence of significantly higher pericardial fat volume in patients with CAD when compared with those without CAD. This association remains statistically significant even after performing a stepwise logistic regression analysis for age, smoking, diabetes, peripheral artery disease, BMI, HTN, hyperlipidaemia, and renal disease ( Table 3 and see Supplementary data online, Table S1 ). Though, the mediastinal and intrathoracic fat volumes were higher among patients with MS; the difference in the mediastinal and intrathoracic fat did not achieve significance for patients with and without CAD. Furthermore, a correlation was noted between the severity of CAD and fat volume for pericardial fat, mediastinal fat, intrathoracic fat, and fat ratio. Our results are in consensus with several previous studies reporting an association between CAD or surrogate markers for CAD and pericardial fat. 1,5,6,10,11,13 -15 Pericardial fat volume has been shown to be more closely associated with early development of CAD compared with BMI and waist circumference among patients with suspected CAD. 16 This could be due to the high content of inflammatory factors and proximity to the coronary arteries. However, any intrathoracic fat volume correlated with the severity of CAD, which is similar to the relationship between CAD and other risk factors such as obesity that correlate with the overall burden of disease. In a study by Jeong et al., 6 an association was found between the severity of CAD in patients with prior angiography and pericardial fat as assessed by echocardiography. In a study of 1267 patients, there was no association of mediastinal fat volume, as assessed by multidetector computed tomography (MDCT), and a composite outcome of cardiovascular diseases; however, there was an association with pericardial fat, but this association did not persist after adjustment for cardiovascular risk factors. 3 Similarly, two other studies have reported no significant association between pericardial fat measured by MDCT and CAD. 17, 18 Several studies have reported a lack of association between pericardial fat and CAD. These studies suffer from lack of standardization, most were case control studies that are more sensitive to confounding bias than a cohort study such as ours. Furthermore these studies have used surrogate outcomes for the assessment of CAD, in our study CAD was assessed by coronary angiography which is considered the gold standard. 17 -20 In contrast to previous studies which used MDCT and Single-photon emission computed tomography as the reference standard, 21,22 the use of X-ray coronary angiography and highly reproducible CMR for the measurement of fat volume reduces the possibility of a type I error. We used a cohort study design, which is less prone to the effect of confounding factors than previously reported case-control study designs. CMR has a distinct advantage, as it does not use radiation to precisely characterize soft tissue. Furthermore, the high-target acquisition and spatial resolution of CMR lead to an excellent reproducibility in calculations and a marked reduction in sample size. Increased pericardial fat might contribute to the progression of CAD by functioning as an inflammatory tissue and facilitating chronic inflammation in epicardial coronary arteries.
Pericardial fat has been shown to have higher concentration of inflammatory cell and increased inflammatory gene expression and protein secretion when compared with subcutaneous fat. 23, 24 Though small in amount, it covers up to 80% of cardiac surface area and directly delivers pro-inflammatory cytokines IL-6, TNF-a, or TLR4 to the myocardium. 3, 25 Pericardial adipose tissue has been shown to be rich in adipocytokine -chemerin, which regulates immune response and lipid metabolism. Pericardial chemerin levels have been strongly correlated with CAD severity. 26 An increase in the amount of pericardial fat has also been shown to be associated with a decrease in concentration of adiponectin, which exerts an antiinflammatory effect via inhibition of NF-kB activity. 27 mechanism. 21, 22, 30 Our results also show an association between pericardial fat and CAD, suggesting its importance as a mediator of systemic CAD risk factors. Mediastinal fat is larger in amount, but unlikely to have the similar paracrine effect on local coronary inflammation as pericardial fat. This could be partly due to distinct biochemical nature, blood supply, and drainage of mediastinal fat. 3, 23 Hence, pericardial fat might act as a local stimulator for coronary atherosclerotic lesion, while mediastinal fat may be a marker of MS and CAD. A potential limitation of our study is related to the measurement of fat by CMR. Since standard imaging includes small gaps between slices, certain assumptions have to be made when calculating fat volume; however, these gaps are small and unlikely to be significant. Furthermore, we used short-axis views to measure mediastinal fat, and this likely underestimated the amount of mediastinal fat volume as the apex is under-represented; for this reason, we added the mediastinal fat volume of a single four-chamber view. Another limitation of this study is a potential selection bias in that all patients had to have both a CMR and a coronary angiography to be enrolled. This may have led to a heterogeneous population, which might not reflect the general population with CAD. There was no significant correlation with intrathoracic fat and major adverse cardiac events. This study was not powered for clinical endpoint and thus any conclusion should be tempered due to small sample size and duration of follow-up. Despite a high accuracy to evaluate pericardial, mediastinal, and intrathoracic adipose tissue, quantification of fat volume with CMR is time consuming and might limit its widespread application. However, our results show a statistically significant correlation between fat volume and fat surface area, which is relatively quick and easy to calculate.
Conclusion
Our study confirms an association between pericardial fat volume with the presence and severity of CAD. Furthermore, an association between mediastinal and intrathoracic fat volumes with MS was found.
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